Roche Diagnostics at a glance

  • Leader in in-vitro diagnostics and tissue-based cancer diagnostics
  • Ranked as the #1 service group in the Canadian diagnostics industry
  • Leader in supply chain amongst Canadian diagnostics manufacturers

Roche Diagnostics – Business overview

Roche is a leader in in-vitro diagnostics, tissue-based cancer diagnostics and a market leader in its sector. In 2017, 19 billion tests were conducted worldwide with our diagnostics products. Roche is working on understanding how diseases differ down to the molecular level, so we can develop new tests and medicines that prevent, diagnose and treat these diseases. Diagnosis is critical and can be complex, requiring specialized laboratory technicians and facilities for testing that may not be accessible to many people. Proper diagnosis is the only way to ensure that the right treatment choice is made. We are working to remove barriers and improve every step of a patient’s journey. Our aim is for every person who needs our diagnostic tests to be able to access them, no matter where they live.

Early, accurate diagnosis can significantly increase a patient’s chance of survival. In breast cancer for example, 98.8% of patients survive five years if diagnosed early compared with only 26.3% if diagnosed with the disease at an advanced stage.1 As a result of modern diagnosis and therapy, breast cancer death rates dropped 39% between 1989 and 2015 in the US.2

Roche Diagnostics gives you the power of knowing that you can be in control of your health today to benefit from a healthier tomorrow.

Roche Diagnostics in Canada

Roche Diagnostics Canada offers a unique broad product portfolio and innovative solutions to hospitals, laboratories, physicians, researchers and patients, in the fields of clinical chemistry, immunology, point-of-care, molecular biology, pathology and life science. Headquartered in Laval, Quebec, our Canadian affiliate employs over 300 people.

Recently, Roche Diagnostics launched its RochePremier program to support laboratories beyond the products and solutions we offer. With the challenges laboratories are facing, Roche Diagnostics Lab Consultancy services enable greater efficiency of resources and support in all aspects of operations. Furthermore, with its recently significant investments, Roche Diagnostics is committed to driving the transformation and becoming a leader in digital diagnostics.

Our service and support team is ranked as the #1 service group in the Canadian diagnostics industry and our Roche Care Call Center is also recognized as part of the top 100 call centers in North America, all industries combined. Our multidisciplinary field-based staff, located coast to coast, quickly assists customers when they need it most. Timely and flawless deployment of solutions are possible with the help of our project management team who can assist in managing change when new lab solutions are implemented. Finally, previous surveys conducted by the Advantage Group identified Roche as the leader in supply chain amongst Canadian diagnostics manufacturers.


1. National Cancer Institute, SEER available at https://seer.cancer. gov/statfacts/html/breast.html

2. DeSantis C E et al. Breast cancer statistics, 2017. A Cancer Journal for Clinicians. DOI: 10.3322/caac.21412, 2017